Live Events

 
Live event schedule coming soon. Questions about upcoming live events can be sent to live@PeerView.com.
September
6
Friday
6:30 PM

B-Cell Lymphoma

Innovative Therapy for B-Cell Malignancies: A MasterClass and Tumor Board on Decision-Making in CLL, FL, and MCL

Chicago, Illinois

Ian W. Flinn, MD, PhD
Sarah Cannon Research Institute
Nashville, Tennessee

September
11
Wednesday
11:00 AM

Immuno-Oncology Biomarkers

A Pan-Cancer, Pan-Biomarker Exploration of the Opportunities to Realize the Potential of Precision Immuno-Oncology: Are Pathology Professionals Ready for the Challenge?

Phoenix, Arizona

Kurt Schalper, MD, PhD
Yale School of Medicine
Yale Cancer Center
New Haven, Connecticut

September
13
Friday
11:00 AM

Leukemia

Pathology Insights on Innovation in AML: The Rapid Emergence of Precision Diagnostics & Novel Therapy Across the Spectrum of Care

Phoenix, Arizona

Carlos E. Bueso-Ramos, MD, PhD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Naval Daver, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
16
Monday
5:45 PM

NSCLC

NSCLC Tumor Board: Navigating the Evolving Role of Immunotherapy in Multimodal Management of Locally Advanced and Early-Stage Lung Cancer

Chicago, Illinois

Roy H. Decker, MD, PhD
Professor & Vice Chair
Director of Clinical Research
Department of Therapeutic Radiology
Yale School of Medicine
New Haven, Connecticut

September
16
Monday
5:45 PM

Solid Tumors

Readying the Modern Radiation Oncology Practice for Incorporation of a Fourth Modality in Cancer Treatment: Understanding the Science, Evidence, & Clinical Application Across a Range of Solid Malignancies

Chicago, Illinois

Matthew T. Ballo, MD, FACR
Professor and Chair of Radiation Oncology
West Cancer Center & Research Institute
Memphis, Tennessee

September
17
Tuesday
6:15 PM

EGFR-Mutant NSCLC

Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes

Chicago, Illinois

Kathryn Beal, MD
Radiation Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York

Sandip Patel, MD
Associate Professor, Department of Medicine
UC San Diego Health
Co-Leader, Experimental Therapeutics
Deputy Director, San Diego Center for Precision Immunotherapy
Assistant Director, Clinical Trials Office
UC San Diego Moores Cancer Center
La Jolla, California

September
20
Friday
12:30 PM

HCC

MasterClass & Tumor Board
Composing Personalized HCC Treatment Strategies: Insights on Harmonizing Patient Care With a Multidisciplinary Ensemble

Chicago, Illinois

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
Weill Medical College at Cornell University
New York, New York

September
23
Monday
5:15 PM

Precision Immuno-Oncology

A Pan-Cancer, Pan-Biomarker Exploration of the Opportunities to Realize the Potential of Precision Immuno-Oncology: Are Pathology Professionals Ready for the Challenge?

Kissimmee, Florida

Lynette M. Sholl, MD
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

September
25
Wednesday
11:00 AM

Asthma

Teaming Up to Overcome Challenges in Severe Asthma Management: The Role of Targeted Therapy in Personalized Care

Philadelphia, Pennsylvania

William J. Calhoun, MD, FACP, FCCP, FAAAAI, FACAAI
University of Texas Medical Branch
Galveston, Texas

Neil Skolnik, MD
Sidney Kimmel Medical College
Thomas Jefferson University
Abington Jefferson Health
Abington, Pennsylvania

September
30
Monday
12:00 PM

Oncologic Emergencies

Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses

Austin, Texas

Sorayah Bourenane, MSN, RN, CNL
Emergency Center (EC) and Clinical Decision Unit (CDU)
The University of Texas MD Anderson Cancer Center
Houston, Texas

Marianne Davies, DNP, ACNP, AOCNP
Yale School of Nursing
Yale Comprehensive Cancer Center & Smilow Cancer Center
New Haven, Connecticut

October
22
Tuesday
5:30 AM

Chronic obstructive pulmonary disease (COPD)

Winning Strategies for Diagnosing and Managing Chronic Obstructive Pulmonary Disease

New Orleans, Louisiana

Fernando J. Martinez, MD, MS
Weill Cornell Medical College
New York-Presbyterian Hospital/
Weill Cornell Medical Center
New York, New York

MeiLan K. Han, MD, MS
University of Michigan
Ann Arbor, Michigan

October
26
Saturday
6:00 PM

Emergency Medicine

Best Practices for Recognizing & Managing Immune-Related Adverse Events in the Emergency Department: Become Aware, Stay Alert, Change Your Practice, & Keep Patients With Cancer Safe

Denver, Colorado

Evan J. Lipson, MD
Bloomberg~Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Baltimore, Maryland

Andrew Stolbach, MD, MPH
Johns Hopkins Hospital
Johns Hopkins University School of Medicine
Baltimore, Maryland

October
29
Tuesday
6:00 AM

Hemophilia

Recognizing and Managing Hemophilia in the Emergency Department in an Era of Expanding Therapeutic Options: A Progress-in-Practice MasterClass and Practicum

Denver, Colorado

Sarah Luisa Melendez, MD
Orlando Health Arnold Palmer Hospital for Children
Orlando, Florida

Doris Quon, MD, PhD
Orthopaedic Hemophilia Treatment Center
Los Angeles, California

November
13
Wednesday
12:30 PM

Rheumatology

Recognizing and Managing Progressive Fibrosing ILD in Patients With Connective Tissue Diseases: Examining the Potential Clinical Implications of Antifibrotic Therapy

Atlanta, Georgia

Lorinda Chung, MD, MS
Stanford University School of Medicine
Palo Alto, California

December
6
Friday
7:00 AM

Lymphoma

“How I Think, How I Treat”
BTK Inhibitors as a Clinical Strategy: Therapeutic Selection, Sequencing, and Next Steps in CLL, MCL, and Beyond

Orlando, Florida

Andre H. Goy, MD
John Theurer Cancer Center
Regional Cancer Care Associates
Georgetown University
Seton Hall
Hackensack Meridian School of Medicine
Hackensack, New Jersey

December
6
Friday
7:00 AM

Lymphoma

Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL

Orlando, Florida

John P. Leonard, MD
Weill Cornell Medicine
New York, New York

January
18
Friday
6:30 PM

HCC

Breaking the Paradox: Expanding Options and New Questions in HCC Management—Mapping the Pathways to Better Patient Outcomes

San Francisco, California

Richard S. Finn, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

February
14
Thursday
6:30 PM

Renal Cell Carcinoma

Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook

San Francisco, California

David F. McDermott, MD
Beth Israel Deaconess Medical Center
Dana-Farber Harvard Cancer Center Kidney Cancer Program
Harvard Medical School
Boston, Massachusettsa

February
15
Friday
6:15 PM

Prostate Cancer

Unraveling the Complexities of Prostate Cancer Management: Focus on Therapeutic Decisions for Early-Stage Disease and the Implications for Later-Stage Disease

San Francisco, California

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

February
20
Wednesday
12:00 PM

Veno-occlusive disease/sinusoidal obstruction syndrome

Attacking the Clinical Problem of VOD/SOS in HCT Recipients: Insights on Pathophysiology, Diagnosis, and Treatment

Houston, Texas

Mitchell S. Cairo, MD
Children and Adolescent Cancer and Blood Diseases Center
Maria Fareri Children’s Hospital
Westchester Medical Center (WMC)
New York Medical College
Valhalla, New York

February
21
Thursday
6:30 AM

Multiple Myeloma

Innovative Therapeutic Concepts for ASCT-Eligible Patients With Myeloma: Advancing Toward More Effective Care Across Treatment Settings

Houston, Texas

Sagar Lonial, MD, FACP
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

February
21
Thursday
12:00 PM

Cytomegalovirus

Managing CMV in the New Era of Antiviral Therapy: Practical Considerations in the HCT Setting

Houston, Texas

Roy F. Chemaly, MD, MPH, FIDSA, FACP
The University of Texas
MD Anderson Cancer Center
Houston, Texas

February
22
Friday
12:00 PM

Graft-Versus-Host Disease

Innovative Therapies in Post-Transplant GVHD: Personal Insights From the Patient CaseBook

Houston, Texas

Madan H. Jagasia, MBBS, MS, MMHC
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Nashville, Tennessee

February
23
Saturday
6:30 AM

CAR-T Cell Therapy

Harnessing Recent Advances in CAR-T Cell Therapy for Leukemia and Lymphoma in the Era of Stem Cell Transplantation

Houston, Texas

Tanya Siddiqi, MD
City of Hope National Medical Center
Duarte, California

February
23
Saturday
12:00 PM

Acute Myeloid Leukemia

Integrating Innovative Therapeutics With Allogeneic HCT in AML: Insights and Evidence From Induction to Maintenance

Houston, Texas

Alexander Perl, MD
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania

February
28
Thursday
7:00 PM

Non–Small Cell Lung Cancer

III, II, I: Addressing Unmet Needs in Earlier Stages of NSCLC With Immunotherapy—Cutting-Edge Research, Clinical Applications, and Practical Challenges

San Francisco, CA

Scott J. Antonia, MD, PhD
Duke Cancer Institute
Durham, North Carolina

March
1
Friday
7:00 PM

Precision Immuno-Oncology

New Frontiers in Precision Immuno-Oncology: Leveraging Biomarkers to Refine and Expand the Use of Cancer Immunotherapies and Combinations

San Francisco, California

Justin F Gainor, MD
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

March
7
Thursday
12:00 PM

Migraine

Recognition and Management of Migraine in an Era of Expanding Options for Acute Treatment and Prevention

Denver, Colorado

Stewart J. Tepper, MD, FAHS
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

March
14
Thursday
6:00 PM
March
15
Friday
4:45 PM

EGFR-Mutant Non–Small Cell Lung Cancer

Refining Current Practice and Exploring New Frontiers in EGFR-Mutant NSCLC: Evolving Science, New Standards of Care, and Implications for Multidisciplinary Management

San Diego, CA

Benjamin Levy, MD
Johns Hopkins School of Medicine
Johns Hopkins Sidney Kimmel Cancer Center (SKCC) at Sibley Memorial Washington DC
Washington, DC

March
20
Wednesday
6:00 AM

Immuno-Oncology

Keeping Up With Advances in Cancer Immunotherapy and Biomarker Testing: Implications for Pathologists at the Forefront of the Emerging Precision Immuno-Oncology Era

National Harbor, Maryland

Robert Anders, MD, PhD
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland

March
27
Wednesday
11:30 AM

Hepatocellular Carcinoma

Rethinking Care in Hepatocellular Carcinoma Amid Expanding Treatment Options: An Interdisciplinary Discussion

Austin, Texas

Richard S. Finn, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

Laura M. Kulik, MD
Northwestern University Feinberg School of Medicine
Chicago, Illinois

March
27
Wed
6:30 PM
March
30
Saturday
6:30 PM

B-Cell Non-Hodgkin Lymphoma

BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond

Atlanta, GA

John C. Byrd, MD
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

April
3
Wed
7:30 AM

Phenylketonuria

Diminishing the Burden of Phenylketonuria During Adulthood: New Science & Encouraging Stories Highlighting the Critical Role of Adjunctive Therapy in Alleviating Neurocognitive Symptoms and Easing Dietary Constraints

Seattle, WA

Jerry Vockley, MD, PhD
University of Pittsburgh
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania

Stephanie Sacharow, MD, FACMG
Harvard Medical School
Boston Children’s Hospital
Boston, Massachusetts

April
11
Thursday
5:30 AM

PARP Inhibitors

Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Oncology Nurses on the Advances and Challenges

Anaheim, California

Kimberly Halla, MSN, FNP-C
Arizona Oncology Associates PC
Scottsdale, Arizona

April
11
Thursday
11:45 AM

B-Cell Malignancies

Taking Aim at B-Cell Malignancies With BTK Inhibitors: Oncology Nurse Perspectives and Insights on Clinical Care

Anaheim, California

Mollie Moran, APRN-CNP, AOCNP
The James Cancer Hospital at The Ohio State University Medical Center
Columbus, Ohio

April
13
Saturday
5:30 AM

Pancreatic Cancer

Clinical Advances in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in a Changing Therapeutic Landscape

Anaheim, California

Gayle Jameson, MSN, ACNP-BC, AOCN
HonorHealth Research Institute
Scottsdale, Arizona

April
14
Sunday
5:30 AM

Lymphoma

An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership

Anaheim, California

Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
Temple/Fox Chase Cancer Center
Philadelphia, Pennsylvania

April
14
Sunday
5:30 AM

CAR-T Cell Therapy

Navigating the CAR-T Cell Therapy Landscape in Hematologic Malignancies: Science and Practical Issues in Nursing Care

Anaheim, California

Susan Blumel, RN, BSN
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska

May
3
Friday
5:30 PM

Bladder Cancer

Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care

Chicago, Illinois

Neal D. Shore, MD, FACS
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina

May
4
Saturday
6:15 AM

Breast Cancer

On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum

Dallas, TX

Elizabeth A. Mittendorf, MD, PhD
Brigham and Women’s Hospital
Dana-Farber/Brigham and Women’s Cancer Center
Boston, Massachusetts

May
5
Sunday
6:00 PM
May
19
Sunday
6:30 PM

Pulmonology

Systemic Sclerosis–Associated Interstitial Lung Disease: Expert Insights on Early Diagnosis and Optimal Management

Dallas, Texas

Marilyn K. Glassberg, MD
University of Miami School of Medicine
Miami, Florida

May
30
Thursday
6:30 AM

Multiple Sclerosis

Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers

Seattle, Washington

Edward J. Fox, MD, PhD
MS Clinic of Central Texas
Central Texas Neurology Consultants
University of Texas Dell Medical School
Round Rock, Texas

May
31
Friday
6:30 PM

Head and Neck Cancer

Mapping Progress With Immune Checkpoint Inhibitors in Head and Neck Cancer: Expert Views on Immunotherapy as a Component of Multimodal Care

Chicago, Illinois

Ezra Cohen, MD, FRCPSC, FASCO
UC San Diego Health
San Diego Center for Precision Immunotherapy
UC San Diego Moores Cancer Center
La Jolla, California

May
31
Friday
6:30 PM

Pancreatic Cancer

Stories From The Pancreatic Cancer CaseBook: Taking the Road to Improved Outcomes With Modern Therapeutic Concepts and Innovative Treatments

Chicago, Illinois

Johanna C. Bendell, MD
Sarah Cannon Research Institute
Nashville, Tennessee

May
31
Friday
6:30 PM

Renal Cell Carcinoma

Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy

Chicago, Illinois

David F. McDermott, MD
Beth Israel Deaconess Medical Center
Dana-Farber Harvard Cancer Center Kidney Cancer Program
Harvard Medical School
Boston, Massachusetts

May
31
Friday
6:30 PM

Lymphoma

A MasterClass on Innovative Therapy in B-Cell Lymphoma: Evidence, Clinical Guidance, and Insights on the Future of Patient Care

Chicago, Illinois

Nathan H. Fowler, MD
The University of Texas MD Anderson Cancer Center
Houston, Texas

May
31
Friday
6:30 PM

Myelofibrosis

MasterClass and Case Forum: Changing the Treatment Story in Myelofibrosis: New Science and More Choices for Challenging Cases in the JAK Inhibitor Era

Chicago, Illinois

Professor Claire Harrison
Guy's and St Thomas' NHS Foundation Trust
South London Genomics Medicine Centre
London, England, United Kingdom

June
1
Saturday
6:30 PM

Prostate Cancer

New Concepts in Prostate Cancer Care: What Oncologists Need to Know to Optimize Patient Outcomes

Chicago, Illinois

Robert Dreicer, MD, MS, MACP, FASCO
University of Virginia Cancer Center
Paul Mellon Urologic Cancer Institute
University of Virginia School of Medicine
Charlottesville, Virginia

June
1
Saturday
6:30 PM

Hepatocellular Carcinoma

“How I Think, How I Treat”—Embarking on a New Treatment Era in Hepatocellular Carcinoma: A Personal Take on Integrating Recent Evidence Into the Continuum of Care for Patients With HCC

Chicago, Illinois

Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
Weill Medical College at Cornell University
New York, New York

June
1
Saturday
6:30 PM

Non—Small Cell Lung Cancer

Candid Conversations About NSCLC—Live From Chicago: Navigating Immunotherapies and Combinations in the Search for the Best Strategy for Each Patient

Chicago, Illinois

Benjamin Levy, MD
Johns Hopkins School of Medicine
Johns Hopkins Sidney Kimmel Cancer Center (SKCC) at Sibley Memorial Hospital
Washington, District of Columbia

November
10
Saturday
7:30 PM

Hepatocellular Carcinoma

Surveying the View From the Driver’s Seat in Hepatocellular Carcinoma: Bringing Into Focus Hepatology’s Key Role in Guiding HCC Care Down the Path to Improved Outcomes

San Francisco, CA

Jorge A. Marrero, MD, MS
UT Southwestern Medical Center
Dallas, Texas

November
11
Sunday
6:00 AM

Cardiology

Following the Evidence: LDL-C as a Path to Reducing Cardiovascular Events—How Low Do We Go?

Chicago, IL

Marc S. Sabatine, MD, MPH
Brigham and Women's Hospital
Harvard Medical School
Boston, Massachusetts

November
15
Thursday
7:00 PM

Sarcoma

The Promise of New Concepts and Innovative Therapy in Advanced Sarcoma: From Established Targets to TRK Inhibition and Beyond

Rome, Italy

George D. Demetri, MD
Dana-Farber Cancer Institute
Ludwig Center at Harvard
Harvard Medical School
Boston, Massachusetts

November
17
Saturday
11:45 AM

Glioblastoma

Transforming Glioblastoma Management: A MasterClass on Evaluating Newer and Emerging Options in the Precision Medicine and Person-Centered Care Era

New Orleans, Louisiana

Steven Brem, MD
Penn Brain Tumor Center
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

November
30
Friday
7:00 AM

Lymphoma

Exploring the Present and Future of BTK Inhibition in B-Cell Malignancies: Expert Insights on Practical Implications for Patient Management

San Diego, California

Andre H. Goy, MD
John Theurer Cancer Center
Seton Hall – Hackensack Meridian School of Medicine
Hackensack, New Jersey

Live event schedule coming soon. Questions about upcoming live events can be sent to live@PeerView.com.
September
6
Friday
7:00 PM

B-Cell Lymphoma

Innovative Therapy for B-Cell Malignancies: A MasterClass and Tumor Board on Decision-Making in CLL, FL, and MCL

Chicago, Illinois

Ian W. Flinn, MD, PhD
Sarah Cannon Research Institute
Nashville, Tennessee

September
26
Thursday
11:00 AM
December
6
Friday
7:30 AM

Lymphoma

Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL

Orlando, Florida

John P. Leonard, MD
Weill Cornell Medicine
New York, New York

November
14
Wednesday
3:00 PM
7:00 PM
November
15
Thursday
7:00 PM

Tardive Dyskinesia

Improving Long-Term Outcomes in Patients With Tardive Dyskinesia: Examining the Impact of New Therapeutic Options

Joseph McEvoy, MD
Medical College of Georgia
Augusta, Georgia

March
1
Friday
7:00 PM

Precision Immuno-Oncology

New Frontiers in Precision Immuno-Oncology: Leveraging Biomarkers to Refine and Expand the Use of Cancer Immunotherapies and Combinations

San Francisco, California

Justin F Gainor, MD
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

March
5
Tue
2:00 PM
March
6
Wed
2:00 PM
7:00 PM

Nontuberculous Mycobacterial Lung Disease

Exploring the Path Forward in Nontuberculous Mycobacterial Lung Disease: A MasterClass on Risk Factors, Diagnosis, and Treatment

David E. Griffith, MD
University of Texas Health Science Center
Tyler, Texas

November
29
Thursday
11:20 AM

Bladder Cancer

Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes

Phoenix, Arizona

Arjun Balar, MD
Laura and Isaac Perlmutter Cancer Center
NYU Langone Health
New York, New York

October
24
Wednesday
6:00 AM

Immuno-Oncology

Incorporating Cancer Immunotherapies Into the Oncology Treatment Arsenal in Managed Care Settings: Navigating the Complexities of Value Assessment & Cost Optimization in the Era of Immuno-Oncology

Orlando, Florida

Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center
Georgetown University School of Medicine
Washington, District of Columbia

James T. Kenney, RPh, MBA
Harvard Pilgrim Health Care
Waltham, Massachusetts

October
23
Tuesday
1:00 PM

Hepatitis C virus

Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

Hagerstown, MD

Mark S. Sulkowski, MD
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

October
23
Tuesday
6:30 PM

Immuno-Oncology Biomarkers

The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies

Robert Anders, MD, PhD
Johns Hopkins University
The Bloomberg~Kimmel Institute for Cancer Immunotherapy
Baltimore, Maryland

October
23
Tuesday
6:00 PM

Immuno-Oncology Biomarkers

The Central Role of Biomarker Testing in Piecing Together the Immuno-Oncology Puzzle: Essential Guidance for Pathologists to Maximize the Potential of Cancer Immunotherapies

Chicago, IL

Robert Anders, MD, PhD
Johns Hopkins University
The Bloomberg~Kimmel Institute for Cancer Immunotherapy
Baltimore, Maryland

October
22
Monday
6:00 PM

EGFR-Mutant NSCLC

Molecular Testing for EGFR Mutations in the Context of a Changing Treatment Landscape, Evolving Testing Options, and New Guidelines: What Pathologists Need to Know and Do

Chicago, IL

Lynette M. Sholl, MD
Brigham and Women’s Hospital
Harvard Medical School
Boston, Massachusetts

October
22
Monday
6:45 PM
October
21
Sunday
5:45 AM

Migraine

Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention: What Are the Potential Implications on Clinical Practice?

Atlanta, GA

Stewart J. Tepper, MD, FAHS
Geisel School of Medicine at Dartmouth
Hanover, New Hampshire

October
13
Saturday
6:00 AM

Lung Cancer

The Evolving Role of Immunotherapy as a Component of Multimodal Therapy in Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Multidisciplinary Care

New York, NY

Naiyer Rizvi, MD
Columbia University Medical Center
New York, New York

Benny Weksler, MBA, MD
University of Tennessee Health Science Center
Methodist University Hospital
Memphis, Tennessee

October
8
Monday
5:45 AM

Asthma

A MasterClass on New Avenues in Asthma Management: Finding the Right Patients for Targeted Therapies

San Antonio, Texas

Jonathan Corren, MD
David Geffen School of Medicine at UCLA
Los Angeles, California

October
4
Thursday
6:00 AM

Immuno-Oncology Biomarkers

Advances and Challenges in Refining the Use of Cancer Immunotherapies Through Biomarker Testing:
Practical Guidance for Pathologists on the Front Lines of the Immuno-Oncology Revolution

Baltimore, MD

Kurt Schalper, MD, PhD
Yale School of Medicine
Yale Cancer Center
New Haven, Connecticut

Edward B. Garon, MD, MS
UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

October
3
Wednesday
11:10 AM

EGFR-Mutant NSCLC

Navigating the Complexities of Molecular Testing for EGFR Mutations to Guide Treatment Selection in Lung Cancer: Evidence, Practicalities, and Implications for Pathologists

Baltimore, MD

Anjali Saqi, MD, MBA
Columbia University Medical Center
New-York Presbyterian Hospital
New York, New York

Pathology Specialist

Geoffrey R. Oxnard, MD
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts

Oncology Specialist
October
2
Tuesday
6:00 AM

Lung Cancer

Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice

New York, NY

Edward B. Garon, MD, MS
UCLA's Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA
Los Angeles, California

September
30
Sunday
6:00 PM

Oncologic Emergencies

Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department

San Diego, California

Daniel Pallin, MD, MPH
Harvard Medical School
Brigham and Women’s Hospital
Boston, Massachusetts

September
26
Wed
3:00 PM

Hemophilia A

Treatment Innovation in Hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice

Mark T. Reding, MD
University of Minnesota
Minneapolis, Minnesota

September
22
Saturday
11:50 AM

Chronic Pain

The Role of Abuse-Deterrent Therapies in a Multimodal Approach to Chronic Pain Management—Improving Outcomes and Averting Medication Misuse

Atlanta, GA

Sanford M. Silverman, MD
Silver Lining Medical Consultants
Coastal Pain Medicine
Pompano Beach, Florida

Florida Society Interventional Pain Physicians
Broward County Medical Association
American Society Interventional Pain Physicians
Florida Society Interventional Pain Physicians
Boca Raton, Florida

September
15
Saturday
6:30 AM

B‑Cell NHL

Integrating BTK Inhibitors Into the Management of B‑Cell Malignancies: How Is Evidence Driving Patient Care?

Houston, TX

Michael Wang, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

September
7
Friday
7:00 PM

Lymphoma

Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL

Chicago, IL

Nathan H. Fowler, MD
The University of Texas
MD Anderson Cancer Center
Houston, Texas

July
9
Monday
5:30 PM

Hepatitis C virus

Addressing the Evolving Opioid and HCV Epidemics Through Community Engagement and Education

Baltimore, MD

Mark S. Sulkowski, MD
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland